Yüklüyor…
Differential gene expression and AKT targeting in triple negative breast cancer
Background: Metastatic triple negative breast cancer (mTNBC) is a heterogeneous disease with poor prognosis. Molecular evolution of TNBC through chemotherapy selection pressure is well recognized but poorly understood. PI3K/AKT/mTOR is one of the most commonly identified oncogenic-driver pathways in...
Asıl Yazarlar: | , , , , , , , , , , |
---|---|
Materyal Türü: | Online Makale Metin |
Dil: | English |
Baskı/Yayın Bilgisi: |
Impact Journals LLC
2019
|
Konular: | |
Online Erişim: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633890/ https://www.ncbi.nlm.nih.gov/pubmed/31320990 http://dx.doi.org/10.18632/oncotarget.27026 |